Tenon Medical Inc. (TNON): Market Cap to Revenue

Symbol and logo of brand Tenon Medical Inc. (TNON)

Tenon Medical, Inc. (TNON) maintains an impeccable reputation among surgeons due to the development of minimally invasive sacral fixation systems. Patents and FDA approval create significant barriers to entry for competitors, solidifying the company's market position. The price-to-sales multiple history allows for an assessment of the current business valuation relative to revenue, where 0.70 serves as the final level marker. The brand is currently actively scaling its innovative Catamaran product line.

TNON Tenon Medical Inc. P/S Multiple (04/28/2023 - 11/14/2026)

Analytical breakdowns for Tenon Medical, Inc (TNON)

- share price and consensus valuation forecast:
General company analysis:TNON tenonmed.com
Core merchandise of Tenon Medical, Inc.

To minimize fundamental risks, investors should select assets with proven market value. The P/S ratio compares the market capitalization of Tenon Medical, Inc. (TNON) to its annual revenue, determining the premium paid per unit of sales. For Tenon Medical, Inc. (TNON), this is critical when scaling the Catamaran system and expanding insurance coverage in the US. Analyzing the P/S ratio chart allows investors to distinguish real growth in implant sales from a speculative rally.

Competitors of Tenon Medical, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|VANI (vivani.com) - Market Cap to Revenue|XTNT: Market Cap to Sales Volume|NMTC (NeuroOne Medical Technologies Corporation) - P/S Multiple|Price to Sales Modular Med MODD|Price-to-Revenue Ratio Myomo, Inc (MYO)|Envoy Medical Inc - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Vivos Therapeutics VVOS|envveno.com (NVNO) - Price to Sales|SINT - Price-to-Revenue Ratio|LFWD (ReWalk Robotics) - Market Cap to Revenue Ratio|AMIX (autonomix.com) - Market Cap to Revenue|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Bone Biologics|Market Cap to Revenue axonics.com (AXNX)|P/S Multiple BIOL|DYNT - Price to Sales|P/S Multiple FNA (Paragon 28)|INVO: Market Cap to Revenue Ratio